Schlagwort: regulatorische Zulassung
36 Mio. EUR für DISCO Pharmaceuticals
36 Mill. EUR Seed – DISCO Pharmaceuticals verschiebt die Grenze dessen, was Onkologie-Start-ups in Deutschland bislang typischerweise erreichen, deutlich nach oben. Wie das Unternehmen...
Surging expected growth of drug approvals over the next decade
In March 2024, we reported a gradual increase of new drug approvals over the past 30 years, combined with an increasing focus on cancer,...

